
zzso syndrome zzso is associated with zzso and zzso without effective pharmacological zzso zzso recently developed for treatment of type 2 diabetes, zzso appetite suppression and weight loss with common side zzso 

The objective of the study was to investigate the initial safety and effectiveness of zzso in adult zzso subjects compared with obese controls zzso 

Eight zzso and 11 zzso patients underwent standardized meal studies after a single zzso injection of 10 zzso zzso or zzso in a zzso crossover zzso 

zzso insulin, zzso zzso zzso zzso zzso zzso zzso zzso zzso and zzso zzso were measured zzso and zzso zzso and zzso were assessed by visual analog zzso Energy expenditure zzso was measured by indirect zzso Side effects were screened during and for 24 h after the zzso 

zzso and zzso patients were matched for zzso age, body mass index, and zzso body zzso In both groups, zzso increased zzso and lowered zzso and insulin levels but increased insulin zzso zzso Side effects were absent in zzso but common in zzso zzso During the zzso zzso zzso and zzso were elevated in zzso zzso zzso decreased zzso zzso and zzso zzso whereas zzso remained zzso Energy expenditure was unchanged by zzso 

Our pilot study demonstrates that zzso is well tolerated in zzso zzso It increases zzso independently of measured appetite hormones, exerting zzso zzso and zzso effects similarly in zzso and zzso zzso zzso prospective studies should investigate whether chronic zzso administration will reduce zzso and overweight in zzso patients without side zzso 

